Please wait while we open this resource.
K
Clinical reviews
GLP-1 RECEPTOR AGONISTS IN OLDER PEOPLE WITH TYPE 2 DIABETES: SAFETY EVIDENCE FROM THE REAL WORLD
Department of Medicine, University of Padova; Laboratory of Experimental Diabetology, Veneto Institute of Molecular Medicine, Padua, Italy
PDF20266 pages1.1 MB
GLP-1 receptor agonists (GLP-1RA) are increasingly used in the management of type 2 diabetes, particularly in older populations. This report discusses the benefits and potential risks associated with GLP-1RA therapy in older adults, emphasizing the need for personalized treatment approaches that consider the unique metabolic and health profiles of this demographic. The authors aim to provide insights into optimizing diabetes management while minimizing adverse effects.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
ADA Consensus Report: MASLD in People With Diabetes
Same clinical topic · Endocrinology
2025 ADA Diabetes Care Standards Updates
Same clinical topic · Endocrinology
METFORMIN―MECHANISMS OF ITS GLYCEMIA-REDUCING EFFECT
Same clinical topic · Endocrinology
SYNDROME OF INAPPROPRIATE ANTIDIURESIS: FROM PATHOPHYSIOLOGY TO MANAGEMENT
Same clinical topic · Endocrinology
GLYCEMIC EMERGENCIES
Same clinical topic · Endocrinology
DIAGNOSIS AND MANAGEMENT OF CENTRAL DIABETES INSIPIDUS IN ADULTS
Same clinical topic · Endocrinology
ANTI-OBESITY DRUGS: COMPREHENSIVE REVIEW AND EMERGING THERAPIES
Same clinical topic · Endocrinology
DRUG DELIVERY SYSTEMS FOR THYROID DISEASE TREATMENT: A MINI REVIEW ON CURRENT THERAPIES AND ALTERNATIVE APPROACHES
Same clinical topic · Endocrinology
OTHER BENEFITS OF CONTROLLING CARBOHYDRATES
Same clinical topic · Endocrinology